Intracerebroventricular B7-H3 CAR T cells for children and young adults with diffuse intrinsic pontine glioma
Nicholas A. Vitanza(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital), Catherine Lindgren(Unknown), Jason S. Hauptman(Seattle Children's Hospital), Susan Holtzclaw(Seattle Children's Hospital), Julie R. Park(Seattle Children's Hospital), Rimas J. Orentas(Capital Caring), Matthew D. Dun(Hunter Medical Research Institute), Hannah E. Goldstein(Seattle Children's Hospital), Joshua A. Gustafson(Seattle Children's Hospital), Michelle Choe(Baylor College of Medicine), Ashley Wilson(Center for Infectious Disease Research), Jessica Foster(Children's Hospital of Philadelphia), Erin Crotty(Seattle Children's Hospital), Catherine M. Albert(Seattle Children's Hospital), Rebecca Ronsley(Seattle Children's Hospital), Francisco A. Perez(Seattle Children's Hospital), Sarah Leary(Seattle Children's Hospital), Stephanie Rawlings-Rhea(Seattle Children's Hospital), Christopher Brown, Wenjun Huang(Lishui Central Hospital), Jason N. Wright(Seattle Children's Hospital), Jeffrey G. Ojemann(Seattle Children's Hospital), Jason Wendler(Pacific Northwest National Laboratory), Ada Kong(Seattle Children's Hospital), Amy Lee(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Navin Pinto(Seattle Children's Hospital), Kristy Seidel(Fred Hutch Cancer Center), Amy Wein(Seattle Children's Hospital), Samuel R. Browd(Seattle Children's Hospital), Adam Beebe, Colleen Annesley(Unknown), Corinne Hoeppner(Seattle Children's Hospital), On Ho, Alison Thomsen(Seattle Children's Hospital), Sowmy Pattabhi, Madison Beam, Marta M. Alonso(BioCruces Health research Institute), Leonel Steinmetzer, Juliane Gust(University of Washington)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k